Navigation Links
Researcher receives $4 million from RWJ Foundation to study health quality reform project
Date:7/1/2008

Dr. Dennis Scanlon, associate professor of health policy and administration in Penn State's College of Health and Human Development, has been awarded a three-year, $4 million grant from the Robert Wood Johnson Foundation (RWJF) to expand an evaluation of a RWJF national initiative, "Aligning Forces for Quality (AF4Q)."

This grant is in addition to an original $3.4-million grant from the Robert Wood Johnson Foundation in 2007 and expands the scope of the project. "AF4Q" aims to bring together patients, health care providers and payers to turn proven practices for improving quality into real results. Through regional collaboratives, it aims to lift the overall quality of health, reduce racial disparities and provide models for national reform.

"Aligning Forces for Quality" is a $300 million initiative involving 14 community-based programs across the U.S.: the Healthy York County Coalition in York, Pa., and others based in Detroit, Mich.; Western New York; Wisconsin; Williamette Valley, Ore; Memphis, Tenn.; Cincinnati and Cleveland, Ohio; Humboldt County, Calif.; Kansas City, Mo.; Maine; Minnesota; Seattle, Wash.; and Western Michigan.

Community teams will strive to improve health care quality for all patients by helping physicians improve the quality of care for patients and by giving consumers information that helps them partner with their doctors in managing their own health and in making informed choices about their health care. The community alliances will also work to improve care inside hospitals, with a special focus on the central role of nursing; and on reducing inequality in care for patients of different races and ethnicities.

The continued role of Scanlon and his research team will be to evaluate the impact of the AF4Q program in the 14 communities. In particular, they will focus on whether the program resulted in changes in the care of patients with chronic illnesses or in improvements in structures and processes that can lead to
'/>"/>

Contact: Vicki Fong
vfong@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cancer cells revert to normal at specific signal threshold, Stanford researchers find
2. Spiritual effects of hallucinogens persist, Johns Hopkins researchers report
3. More severe bone infections, health complications in children linked to MRSA, researchers find
4. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
5. Researchers study hidden homicide trend
6. Researchers identify promising cancer drug target in prostate tumors
7. CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancer
8. LA BioMed researcher named Hero of Emergency Medicine
9. Pediatrics review of underage drinking prevention programs led by Iowa State researcher
10. Researchers Revisit Edison's Method of Generating Olympic Level Ideas via Unique New Corporate Seminar
11. Researchers develop neural implant that learns with the brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a leading ... devices that enable the Internet of Things (IoT), announced its new medical panel ... provide exceptional computing power and multitasking capabilities. The MLC 4-21 is completely fanless, ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
(Date:7/28/2015)... ... July 28, 2015 , ... On July 16th ... to schedule the hearing of proposed bills and laws revolving the implementation of a ... to date. Some vigilante ministers are continuing to hand out clean needles to drug ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, Inc. , a ... the treatment of bone disorders and conditions of hair loss, announced that the ... of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims methods of use ...
(Date:7/28/2015)... ... ... Fertility specialist Dr. Lisa Hasty of Atlanta Center for Reproductive ... Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for the fifth ... metro area as one of the most respected doctors in Reproductive Endocrinology. , “I’m ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... 7,000 cancer tumour samples for researchers all over the world ... the world over are hailing this step as a major ... truly international. ,"Cancer is not just one disease, ... misbehaving. Since it is multiple diseases, you have to have ...
... death has been reported in Egypt, the most populous North ... woman //, indeed died as a consequence of the highly ... from Nawa village in Qalyubiya, some 40 km north of ... she had been treated for flu-like symptoms, the health ministry ...
... the avian influenza H5N1 virus is receiving samples from across ... arrive each week, packed in ice boxes. // These samples ... chicken deaths and from routine surveillance sites. , ... Animal Disease Laboratory in Bhopal, is running out of space ...
... in kidney transplant recipients can be used in treatment ... 40 years ago, is still used to prevent the ... ,In around the 1960s, Roy Calne showed that ... this finding, a combination of azathioprine and corticosteroids were ...
... the direction of development of prosthetic limbs researchers at University ... by alcohol and hydrogen. // ,As it appears ... than the body's own. ,Two types of ... Institute at the University of Texas in Dallas, working with ...
Cached Medicine News:Health News:Romantic and discreet trends in lingerie 2Health News:Azathioprine Can Soon Revolutionize Eczema Treatment 2
(Date:7/28/2015)... 2015  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... financial results after the market closes on Tuesday, August ... conference call the same day at 4:30 p.m. ET ... provide a corporate update. The live call ...
(Date:7/28/2015)...  Champions Oncology, Inc. (OTC: CSBR), engaged in the ... the development and use of oncology drugs, today announced ... 2015. Fourth Quarter and Recent Business Highlights: ... prior year period result , Procured a quarterly ... Joel Ackerman, Champions Oncology CEO, stated, "The end of ...
(Date:7/28/2015)... July 28, 2015  Cepheid (Nasdaq: CPHD ... and portable clinical molecular diagnostic system designed to ... market.  At just 9 inches tall, and weighing ... the same high quality PCR-based Xpert® cartridges as ... accurate clinical molecular diagnostic tests to be performed ...
Breaking Medicine Technology:Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 4
... Expand Testing Using Cellular ... Antioxidant Activity Assay, ... with the release of results from a new study,showing Wild ... red grapes and strawberries in an expanded,test using the Cellular ...
... Oct. 8 Vical Incorporated (Nasdaq: VICL ... nonclinical data,demonstrating that the company,s Vaxfectin(R) adjuvant may ... vaccines and,peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., ... present the data today,Wednesday, October 8, at the ...
Cached Medicine Technology:Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: